Among sickle cell anemia (SCA) complications, proliferative sickle cell retinopathy (PSCR) is one of the most important, being responsible for visual impairment in 10–20% of affected eyes. The aim of this study was to identify differentially expressed genes (DEGs) present in pathways that may be implicated in the pathophysiology of PSCR from the transcriptome profile analysis of endothelial progenitor cells. RNA-Seq was used to compare gene expression profile of circulating endothelial colony-forming cells (ECFCs) from HbSS patients with and without PSCR. Furthermore, functional enrichment analysis and protein–protein interaction (PPI) networks were performed to gain further insights into biological functions. The differential expression analysis identified 501 DEGs, when comparing the groups with and without PSCR. Furthermore, functional enrichment analysis showed associations of the DEGs in 200 biological processes. Among these, regulation of mitogen-activated protein (MAP) kinase activity, positive regulation of phosphatidylinositol 3-kinase (PI3K), and positive regulation of Signal Transducer and Activator of Transcription (STAT) receptor signaling pathway were observed. These pathways are associated with angiogenesis, cell migration, adhesion, differentiation, and proliferation, important processes involved in PSCR pathophysiology. Moreover, our results showed an over-expression of VEGFC (vascular endothelial growth factor–C) and FLT1 (Fms-Related Receptor Tyrosine Kinase 1) genes, when comparing HbSS patients with and without PSCR. These results may indicate a possible association between VEGFC and FLT1 receptor, which may activate signaling pathways such as PI3K/AKT and MAPK/ERK and contribute to the mechanisms implicated in neovascularization. Thus, our findings contain preliminary results that may guide future studies in the field, since the molecular mechanisms of PSCR are still poorly understood.
ElagouzMJyothiSGuptaBSivaprasadS. Sickle cell disease and the eye: old and new concepts.Surv Ophthalmol2010;55:359–77
4.
ConranNFranco-PenteadoCFCostaFF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.Hemoglobin2009;33: 1–16
5.
LuttyGAMcLeodDSPennJ. Angiogenesis in sickle cell retinopathy. Retinal and choroidal angiogenesis. Dordrecht: Springer, 2008
6.
AlRyalatSANawaisehMAladwanBRotoAAlessaZAl-OmarA. Ocular manifestations of sickle cell disease: signs, symptoms and complications.Ophthalmic Epidemiol2020;27:259–64
7.
DownesSMHambletonIRChuangELLoisNSerjeantGRBirdAC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.Ophthalmology2005;112:1869–75
8.
ScottAW. Ophthalmic manifestations of sickle cell disease.South Med J2016;109:542–8
9.
BrasileiroFMartinsTTCamposSBAndrade NetoJLBravo-FilhoVTAraújoASArantesTE. Macular and peripapillary spectral domain optical coherence tomography changes in sickle cell retinopathy.Retina2015;35:257–63
10.
CampochiaroPA. Molecular pathogenesis of retinal and choroidal vascular diseases.Prog Retin Eye Res2015;49:67–81
11.
IngramDAMeadLETanakaHMeadeVFenoglioAMortellKPollokKFerkowiczMJGilleyDYoderMC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.Blood2004;104:2752–60
12.
LinYWeisdorfDJSoloveyAHebbelRP. Origins of circulating endothelial cells and endothelial outgrowth from blood.J Clin Invest2000;105:71–7
13.
MedinaRJBarberCLSabatierFDignat-GeorgeFMelero-MartinJMKhosrotehraniKOhnedaORandiAMChanJKYYamaguchiTVan HinsberghVWMYoderMCStittAW. Endothelial progenitors: a consensus statement on nomenclature.Stem Cells Transl Med2017;6: 1316–20
14.
CahoonJMRaiRRCarrollLSUeharaHZhangXO’NeilCLMedinaRJDasSKMuddanaSKOlsonPRNielsonSWalkerKFloodMMMessengerWBArcherBJBarabasPKrizajDGibsonCCLiDYKohGYGaoGStittAWAmbatiBK. Intravitreal AAV2.COMP-Ang1 prevents neurovascular degeneration in a murine model of diabetic retinopathy.Diabetes2015;64:4247–59
15.
MedinaRJO’NeillCLHumphreysMWGardinerTAStittAW. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy.Invest Ophthalmol Vis Sci2010;51: 5906–13
16.
BertelliPMPedriniEGuduric-FuchsJPeixotoEPathakVStittAWMedinaRJ. Vascular regeneration for ischemic retinopathies: hope from cell therapies.Curr Eye Res2020;45:372–84
17.
GoldbergMF. Classification and pathogenesis of proliferative sickle retinopathy.Am J Ophthalmol1971;71:649–65
LiaoYSmythGKShiW. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads.Nucleic Acids Res2019;47:e47
21.
LoveMIHuberWAndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol2014;15:550
22.
BligheKRanaSLewisM. Enhanced volcano: publication-ready volcano plots with enhanced colouring and labeling. R package version 1.16.0, 2022, https://github.com/kevinblighe/EnhancedVolcano
23.
MetsaluTViloJ. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap.Nucleic Acids Res2015;43:W566–70
24.
BaderGDHogueCW. An automated method for finding molecular complexes in large protein interaction networks.BMC Bioinformatics2003;4:2
25.
LoisNMcCarterRVO’NeillCMedinaRJStittAW. Endothelial progenitor cells in diabetic retinopathy.Front Endocrinol (Lausanne)2014;5:44
26.
ReidEGuduric-FuchsJO’NeillCLAllenLDChambersSEJStittAWMedinaRJ. Preclinical evaluation and optimization of a cell therapy using human cord blood-derived endothelial colony-forming cells for ischemic retinopathies.Stem Cells Transl Med2018;7:59–67
27.
Fernandez-LASanz-RodriguezFZarrabeitiaRPérez-MolinoAHebbelRPNguyenJBernabéuCBotellaLM. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.Cardiovasc Res2005;68:235–48
28.
CritserPJYoderMC. Endothelial colony-forming cell role in neoangiogenesis and tissue repair.Curr Opin Organ Transplant2010;15:68–72
29.
AuPDaheronLMDudaDGCohenKSTyrrellJALanningRMFukumuraDScaddenDTJainRK. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.Blood2008;111:1302–5
30.
LiaoGZhengKShorrRAllanDS. Human endothelial colony-forming cells in regenerative therapy: a systematic review of controlled preclinical animal studies.Stem Cells Transl Med2020;9:1344–52
31.
JeeKRodriguesMKashiwabuchiFApplewhiteBPHanILuttyGGoldbergMFSemenzaGLMontanerSSodhiA. Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.Plos One2017;12:e0183320
32.
CordoverEMindenA. Signaling pathways downstream to receptor tyrosine kinases: targets for cancer treatment.J Cancer Metastasis Treat2020;6:45
33.
ZhangJTangXJinZZhangH. Interleukin-6 promotes cervical cancer development through janus kinase 2/signal transducer and activator of transcription 6 signaling pathway.J Biomater Tiss Eng2021;11:76–83
34.
CantleyLC. The phosphoinositide 3-kinase pathway.Science2002;296: 1655–7
35.
AliagaJCDeschênesCBeaulieuJFCalvoELRivardN. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells.Am J Physiol1999;277:G631–41
36.
PearsonGRobinsonFBeers GibsonTXuBEKarandikarMBermanKCobbMH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.Endocr Rev2001;22:153–83
37.
ZhangWLiuHT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells.Cell Res2002;12:9–18
38.
SantarpiaLLippmanSMEl-NaggarAK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.Expert Opin Ther Targets2012;16:103–19
39.
KnightTIrvingJA. Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting.Front Oncol2014;4:160
40.
CsehBDomaEBaccariniM. “RAF” neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.FEBS Lett2014;588:2398–406
41.
MendozaMCErEEBlenisJ. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.Trends Biochem Sci2011;36:320–8
42.
CargnelloMRouxPP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.Microbiol Mol Biol Rev2011;75:50–83
43.
ChangYCSuCYChenMHChenWSChenCLHsiaoM. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis.Mol Cancer2017;16:135
44.
KatsoROkkenhaugKAhmadiKWhiteSTimmsJWaterfieldMD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.Annu Rev Cell Dev Biol2001; 17:615–75
45.
MorelloFPerinoAHirschE. Phosphoinositide 3-kinase signalling in the vascular system.Cardiovasc Res2009;82:261–71
46.
NeufeldGCohenTGengrinovitchSPoltorakZ. Vascular endothelial growth factor (VEGF) and its receptors.FASEB J1999;13:9–22
47.
JoukovVKumarVSorsaTArighiEWeichHSakselaOAlitaloK. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.J Biol Chem1998;273:6599–602
48.
PourgholamiMHMorrisDL. Inhibitors of vascular endothelial growth factor in cancer.Cardiovasc Hematol Agents Med Chem2008;6:343–7
AndersonEMKweeBJLewinSARaimondoTMehtaMMooneyDJ. Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia.Tissue Eng Part A2015;21:1217–27
51.
GrunewaldMAvrahamIDorYBachar-LustigEItinAJungSYungSChimentiSLandsmanLAbramovitchRKeshetE. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.Cell2006;124:175–89
52.
TakahashiTKalkaCMasudaHChenDSilverMKearneyMMagnerMIsnerJMAsaharaT. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.Nat Med1999;5:434–8
53.
GuillemVCalabuigMBrunetSEsteveJEscodaLGallardoDRiberaJMQueipodeLlanoMPArnanMPedroCAmigoMLMartí-TutusausJMGarcía-GuiñónABargayJSampolASalameroOFontLTalarnCHoyosMDíaz-BeyáMGarridoANavarroBNomdédeuJSierraJTormoM. Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.Leuk Lymphoma2018;59:2383–93
54.
SoloveyAGuiLRamakrishnanSSteinbergMHHebbelRP. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells.Blood1999;93:3824–30
55.
CaoJMathewsMKMcLeodDSMergesCHjelmelandLMLuttyGA. Angiogenic factors in human proliferative sickle cell retinopathy.Br J Ophthalmol1999;83:838–46
56.
Chang MilbauerLWeiPEnensteinJJiangAHilleryCAScottJPNelsonSCBodempudiVTopperJNYangRBHirschBPanWHebbelRP. Genetic endothelial systems biology of sickle stroke risk.Blood2008;111:3872–9
57.
MikirovaNAJacksonJAHunninghakeRKenyonJChanKWSwindlehurstCAMinevBPatelANMurphyMPSmithLAlexandrescuDTIchimTERiordanNH. Circulating endothelial progenitor cells: a new approach to anti-aging medicine?J Transl Med2009;7:106
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
